Clinical Trials Logo

Neoplasms by Histologic Type clinical trials

View clinical trials related to Neoplasms by Histologic Type.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT04697446 Enrolling by invitation - Neoplasms Clinical Trials

External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC

Start date: December 1, 2020
Phase:
Study type: Observational

This is an external control, observational, retrospective study designed to compare clinical outcomes for pralsetinib compared with best available therapy for patients with RET-fusion positive advanced NSCLC.